UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise in halting pancreatic cancer
Disease control OngoingThis study tests whether a combination of two drugs, lenvatinib and pembrolizumab, can help keep advanced pancreatic cancer from getting worse in people whose cancer cannot be removed by surgery. About 28 adults who have already responded to initial treatment will receive these d…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
Sound waves boost chemo in tough pancreatic cancer trial
Disease control OngoingThis study tests a technique called sonoporation, which uses ultrasound and tiny bubbles to help chemotherapy drugs get into cancer cells more effectively. It includes 120 adults with advanced or hard-to-remove pancreatic cancer who are already scheduled for standard chemotherapy…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Flemming Forsberg • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New immune cell therapy targets five Hard-to-Treat cancers
Disease control TerminatedThis early-stage trial was designed to test the safety of a new treatment called STIL101 for people with advanced pancreatic, colorectal, kidney, cervical cancer, or melanoma that has spread or cannot be removed. The treatment uses a patient's own immune cells (T cells) taken fro…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Desperate patients get early access to experimental cachexia drug
Symptom relief NO_LONGER_AVAILABLEThis program gives seriously ill adults with advanced pancreatic cancer and severe weight loss (cachexia) access to an experimental drug called mifomelatide before it is officially approved. It is for patients who have no other good treatment options for their weight loss and can…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: Endevica Bio • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC